Complications of parenteral nutrition at the end of the century

Clinical Nutrition

Volumn 19, Issue 5, 2000, Pages 295-304

  Maroulis, John ^a   Kalfarentzos, Fotis ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Metabolic complications; Parenteral nutrition; Sepsis; Subclavian catheter complications; Subclavian vein thrombosis

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CHLORHEXIDINE; FIBRINOGEN; GLUCOSE; HEPARIN; HYDROCHLORIC ACID; INSULIN; IODINE; LIPID EMULSION; MAGNESIUM; MINOCYCLINE; OMEGA 6 FATTY ACID; PHOSPHORUS; POTASSIUM; POTASSIUM CHLORIDE; POVIDONE IODINE; RIFAMPICIN; SAFFLOWER OIL; SODIUM; SOYBEAN OIL; STREPTOKINASE; SULFADIAZINE SILVER; THROMBIN; UNINDEXED DRUG; ZINC;

ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ANTISEPSIS; ARTERY INJURY; ATROPHY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHOLESTASIS; COPPER DEFICIENCY; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL DISEASE; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOLIPEMIA; INFECTION RISK; INTRAVENOUS CATHETER; LIVER DYSFUNCTION; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; OSTEOPOROSIS; PARENTERAL NUTRITION; PNEUMOTHORAX; REVIEW; SAFETY; SELENIUM DEFICIENCY; SEPSIS; SUBCLAVIAN VEIN; SUBSTITUTION THERAPY; TOTAL PARENTERAL NUTRITION; VEIN THROMBOSIS; ZINC DEFICIENCY;

EID: 0033764941     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.1999.0089     Document Type: Review

References (122)

1. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance
2. Septic and technical complications of central venous catheterization
3. Delayed pneumothorax, a complication of subclavain vein catheterization
4. The incidence of delayed pneumothorax as a complication of subclavain vein catheterization
5. Central venous catheter replacement with the aid of wire indroducer in patients receiving total parenteral nutrition
6. Fatal subclavain artery haemorrhage. A complication of subclavain vein catheterization
7. Air embolism: A lethal but preventable complication of subclavain vein catheterization
8. A new complication of subclavain vein catheterization
9. Incidence and prevention of thrombosis of the subclavain vein during total parenteral nutrition
10. Restoring patency of occluded central venous catheters
11. Defining intravascular-catheter-related infections: A plea for uniformity
12. Guidelines for prevention of intravascular-device-related infections
13. Central venus access-catheters, technology and physiology
14. Current laboratory techniques in the diagnosis of catheter-related infections
15. A semiquantitative culture method for identifying intravenous catheter-related infections
16. Earlier positivity of central-versus peripheral-blood cultures is highly predictive of catheter-related sepsis
17. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia
18. Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in intensive care units
19. Evaluation of central venous catheter sepsis by differential quantitative culture
20. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15-year period (1978-1992)
21. Prosthetic device infections in surgery
22. Impact of bacterial biofilm formation on in-vitro activities of antibiotics
23. Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents
24. Major trends in the microbial etiology on nosocomial infection
25. Staphylococcus aureus
26. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
27. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
28. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
29. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
30. Candida
31. The use of biotype and DNA fingerprinting in typing Candida albicans from hospitalized patients
32. Nationwide epidemic of septicemia caused by contaminated intravenous products
33. Hickman catheter sepsis: Efficacy of antibiotic lock therapy
34. Biomatelials used for catheters
35. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters
36. Infections caused by arterial catheters used for hemodynamic monitoring
37. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple lumen catheter-related sepsis in patients treated with immunotherapy
38. The value of prophylatic antibiotics during insertion of long-term indwelling silastic right atrial catheters in cancer patients
39. Etiology of catheter-associated sepsis: Correlation with thrombogenicity
40. Central vein catheter-related thrombosis in intensive care patients. Incidence, risk factors, and relationship with catheter-related sepsis
41. Prevention of intravascular-catheter related infections
42. Prospective multicenter study of vascular catheter-related complication and risk factors for positive central-catheter cultures in intensive care unit patients
43. Peripheral access options
44. Subclavain vein catheterization: A prospective study. I. Noninfectious complications
45. Assessment of catheter-associated infection risk with the Hickman right atrial catheter
46. Do multi-lumen catheters increase central venous catheter sepsis compared to single-lumen catheters?
47. TPN via multilumen catheters does not increase the risk of catheter-related sepsis: A randomized, prospective study
48. Complications and management of implanted venous catheters
49. Complication from long-term indwelling central venous catheters in hematologic malignancy patients with special reference to infection
50. Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition: A controlled trial
51. TPN catheter sepsis: Impact of the team approach
52. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters, a prospective study utilizing molecular subtyping
53. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
54. Hub colonization as the initial step in outbreaks of catheter-related sepsis due to coagulase-negative staphylococci during parenteral nutrition
55. Infection due to infusion therapy
56. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving TPN
57. The mythology of povidone-iodine and the development of self-sterilizing plastics
58. An evaluation of iodophors as skin antiseptics
59. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate
60. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters
61. A prospective random study comparing transparent and dry gauze dressing for central venous catheters
62. Prevention and treatment of central venous catheter sepsis by exchange via a guidewire: A prospective controlled trial
63. Vascular access devices: Perspectives on designs, complications, and management
64. A controlled trial of scheduled replacement of central venous and pulmonary-arterial catheters
65. Management of infections in adult intensive care units
66. Intravenous-related infections
67. Prevention of catheter sepsis: The hub
68. Relevance of the catheter hub as a portal for microorganisms causing catheter-related bloodstream infections
69. Elimination of intraluminal colonization by antibiotic lock (AL) in silastic catheters
70. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheter
71. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection
72. An attachable silver impregnated cuff for prevention of infection with central venous catheters: A prospective, randomized, multicenter trial
73. A prospective randomized evaluation of the effect of silver-impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients
74. Efficacy of antiseptic impregnated central venous catheters in preventing catheter-related bloodstream infection
75. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial
76. Antibacterial effects of silver electrodes with weak direct current
77. Antimicrobial activity and action of silver
78. Catheter-related complications of cancer therapy
79. Source and route of microbial colonization of parenteral nutrition catheters
80. Complications in vascular access devices
81. Antibiotic therapy of catheter infections in patients receiving home parenteral nutrition
82. Catheter-related infections associated with home parenteral nutrition and predictive factors for the need for catheter removal in their treatment
83. Primary subclavain vein thrombosis and pulmonary embolism
84. Clinical evaluation of elastromeric hydrogel peripheral catheters during home infusion therapy
85. Complications of intravenous therapy: A randomized prospective study-Vialon vs Teflon
86. Thromboembolic complications with silicone elastomer subclavain catheters
87. Subclavin thrombosis due to indwelling catheters. A prospective study on 52 patients
88. Central venous catheter-associated thrombosis in severe haemophilia
89. Efficacy of thrombolytic therapy for occlusion of long-term catheters
90. Incidence and prevention of thrombosis of the subclavian vein during total parenteral nutrition
91. Nutrition Support: Theory and Therapeutics
92. 3 and candida albicans
93. Early postoperative glucose. Control predicts nosocomial infection rate in diabetic patients
94. Host defenses and susceptibility to infection in patients with diabetes mellitus
95. Hyperosmolar, hyperglycemic, non-ketotic dehydration-etiology, pathophysiology and prevention during total parenteral alimentation
96. Hyperglycemia eliminated immunoglobulins ability to enhance survival in septic asplenic infant rats
97. Dietary augmentation of donor specific transfusion and cyclosporin effects with dietary linoleic acid
98. The effect of dietary fatty acids on response to Pseudomonas infection in burned mice
99. Cardiomyopathy associated with nonendemic selenium deficiency in a Causasian adolescent
100. An accidental case of cardiomyopathy and selenium deficiency
101. Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition
102. Selenium deficiency and fatal cardiomyopathy in a patient receiving long-term home parenteral nutrition
103. Cardiomyopathy and selenium deficiency in a two-year-old girl
104. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition
105. Total parenteral nutrition-associated liver dysfunction
106. Hepatic steatosis in total parenteral nutrition: Failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels
107. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by parenteral nutrition
108. Reduced metabolic complications in total parenteral nutrition: Pilot study using fat to replace one third of glucose calories
109. Total parenteral nutrition-associated liver dysfunction
110. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans
111. Enternal nutrition
112. Maintenance of small bowel mucosa with glutamine-enriched parenteral nutrition
113. Glutamine and the preservation of gut integrity
114. Effect of rate of enteral nutrition supply on gut mass
115. Metabolic bone assessment in patients with inflammatory bowel disease
116. A controlled study of bone mineral density in patients with inflammatory bowel disease
117. Bluestone retal, bone disease associated with total parenteral nutrition
118. Metabolic bone disease in patients receiving long term total parenteral nutrition
119. Multifactorial low remodeling bone disease during cyclic total parenteral nutrition